Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study
布伦妥昔单抗联合吉西他滨治疗复发或难治性外周T细胞淋巴瘤：一项LYSA II期研究
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015787
Tournilhac, Olivier; Bouabdallah, Kamal; Lecolant, Solène; Hacini, Maya; Laribi, Kamel; Bailly, Sébastien; Belmondo, Thibaut; Maerevoet, Marie; Ysebaert, Loic; Guidez, Stéphanie; Le Gouill, Steven; Bonnet, Christophe; André, Marc; Dupuis, Jehan; Thieblemont, Catherine; Bachy, Emmanuel; Daguindau, Nicolas; Morschhauser, Franck; Tricot, Sabine; Moulin, Charline; Banos, Anne; Houot, Roch; Chauchet, Adrien; Gyan, Emmanuel; Cartron, Guillaume; Farhat, Hassan; Camus, Vincent; Drenou, Bernard; Zerazhi, Hacene; Sibon, David; Nicolas-Virelizier, Emmanuelle; Delette, Caroline; Snauwaert, Sylvia; Bailly, Sarah; Delarue, Richard; Carras, Sylvain; Ledoux-Pilon, Albane; Parrens, Marie-Cécile; Griolet, Samuel; Gaulard, Philippe; Delfau-Larue, Marie-Hélène; de Leval, Laurence; Damaj, Gandhi Laurent
